{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:51:55Z","timestamp":1792597915540,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.wneu.2012.01.060","type":"journal-article","created":{"date-parts":[[2012,2,10]],"date-time":"2012-02-10T22:25:15Z","timestamp":1328912715000},"page":"149-153","source":"Crossref","is-referenced-by-count":14,"title":["Incidental Consequences of Antihelmintic Treatment in the Central Nervous System"],"prefix":"10.1016","volume":"79","author":[{"given":"Rodrigo","family":"Ramos-Z\u00fa\u00f1iga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Ra\u00fal","family":"P\u00e9rez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"J\u00e1uregui-Huerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"del Sol L\u00f3pez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jazm\u00edn Elizabeth","family":"Valera-Liz\u00e1rraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Paz-V\u00e9lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad\u00e1n","family":"Becerra-Valdivia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2012.01.060_bib1","first-page":"93","article-title":"Neurocysticercosis: its aetiopathogenesis, clinical manifestations, diagnosis and treatment","volume":"43","author":"Alarcon","year":"2006","journal-title":"Rev Neurol"},{"key":"10.1016\/j.wneu.2012.01.060_bib2","first-page":"679","article-title":"Population pharmacokinetics of albendazole in patients with neurocysticercosis","volume":"47","author":"Castro","year":"2009","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.wneu.2012.01.060_bib3","first-page":"583","article-title":"Neurocysticercosis: an old disease with new questions","volume":"39","author":"Cook","year":"1994","journal-title":"J Fam Pract"},{"key":"10.1016\/j.wneu.2012.01.060_bib4","first-page":"279","article-title":"Clinical evaluation of albendazole and praziquantel in the treatment of cerebral cysticercosis","volume":"22","author":"Cruz","year":"1991","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.wneu.2012.01.060_bib5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0035-9203(91)90041-V","article-title":"Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation","volume":"85","author":"Cruz","year":"1991","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.wneu.2012.01.060_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/ncpneuro0378","article-title":"Do patients with neurocysticercosis benefit from cysticidal therapy?","volume":"3","author":"Davis","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.wneu.2012.01.060_bib7","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1212\/WNL.52.5.1079","article-title":"Single-day praziquantel versus 1-week albendazole for neurocysticercosis","volume":"23","author":"Del Brutto","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2012.01.060_bib8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/clinids\/17.4.730","article-title":"Therapy for neurocysticercosis: a reappraisal","volume":"17","author":"Del Brutto","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.wneu.2012.01.060_bib9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1474-4422(05)70194-0","article-title":"Neurocysticercosis: updated concepts about an old disease","volume":"4","author":"Garcia","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.wneu.2012.01.060_bib10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CMR.15.4.747-756.2002","article-title":"Current consensus guidelines for treatment of neurocysticercosis","volume":"15","author":"Garc\u00eda","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.wneu.2012.01.060_bib11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/QCO.0b013e32834a1b20","article-title":"Cysticercosis of the central nervous system: how should it be managed?","volume":"24","author":"Garcia","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.wneu.2012.01.060_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2125.2011.03945.x","article-title":"Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis","volume":"72","author":"Garcia","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.wneu.2012.01.060_bib13","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jocn.2007.10.004","article-title":"Endoscopic management of intraventricular neurocysticercosis","volume":"15","author":"Goel","year":"2008","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.wneu.2012.01.060_bib14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/01.wnl.0000195887.63124.dc","article-title":"Albendazole trial at 15 or 30 mg\/kg\/day for subarachnoid and intraventricular cysticercosis","volume":"14","author":"Gongora-Rivera","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2012.01.060_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1017\/S0317167100006417","article-title":"Intraventricular neurocysticercosis managed with albendazole and dexamethasone","volume":"36","author":"Hajek","year":"2009","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.wneu.2012.01.060_bib16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.surneu.2004.02.033","article-title":"Neurocysticercosis: a review","volume":"63","author":"Hawk","year":"2005","journal-title":"Surg Neurol"},{"key":"10.1016\/j.wneu.2012.01.060_bib17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1371\/journal.pntd.0000194","article-title":"Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials","volume":"3","author":"Matthaiou","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.wneu.2012.01.060_bib18","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.5858\/2008-0756-RS.1","article-title":"Neurocysticercosis","volume":"134","author":"Moskowitz","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.wneu.2012.01.060_bib19","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1371\/journal.pntd.0000870","article-title":"A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy","volume":"4","author":"Ndimubanzi","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.wneu.2012.01.060_bib20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.trstmh.2005.06.028","article-title":"Pleomorphism of the clinical manifestations of neurocysticercosis","volume":"100","author":"Patel","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.wneu.2012.01.060_bib21","first-page":"805","article-title":"Update in neurocysticercosis treatment","volume":"36","author":"P\u00e9rez-L\u00f3pez","year":"2003","journal-title":"Rev Neurol"},{"key":"10.1016\/j.wneu.2012.01.060_bib22","first-page":"331","article-title":"Clinical manifestations of neurocysticercosis","volume":"24","author":"San-Juan Orta","year":"2009","journal-title":"Neurologia"},{"key":"10.1016\/j.wneu.2012.01.060_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00007691-199702000-00009","article-title":"Therapy for neurocysticercosis: pharmacokinetic interaction of albendazole sulfoxide with dexamethasone","volume":"19","author":"Takayanagui","year":"1997","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.wneu.2012.01.060_bib24","first-page":"543","article-title":"Neurocysticercosis: clinical manifestations and problems in diagnosis","volume":"27","author":"Venkataraman","year":"1979","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.wneu.2012.01.060_bib25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0065-308X(05)61012-3","article-title":"Control of Taenia solium cysticercosis\/taeniosis","volume":"61","author":"Willingham","year":"2006","journal-title":"Adv Parasitol"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875012001337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875012001337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T20:29:15Z","timestamp":1640723355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875012001337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1878875012001337"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2012.01.060","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}